10.3810/psm.2012.11.1988 76 GrsselS.MuschterD
Still, this is the first time researchers have been able to put numbers to these risks, which have previously only been described by doctors and patients who have noticed them
Available aggregate data suggest that glucagon-like peptide-1 (GLP-1) receptor agonists (exenatide, liraglutide, lixisenatide, dulaglutide, or semaglutide) are not associated with AF onset, with the only possible exception of albiglutide [98, 99]
It has not been evaluated or approved by the U.S
If youre ready to find out whether you qualify, check your eligibility through TrimRxs intake assessment and connect with a licensed provider who can review your options
Hepatic effets: Elevations of one or more of the liver enzymes may occur with diclofenac treatment